UCB To Acquire Candid Therapeutics For Up To $2.2 Billion - Pulse 2.0
UCB→Candid Therapeutics
May 4, 2026
Pinnaql has completed the acquisition of Pharma Resource Group, a healthcare services other business in New York. Pinnaql acquisitions focus on expanding healthcare services capabilities, and the Pharma Resource Group acquisition adds operational support for healthcare customers across NY. The add on acquisition strengthens Pinnaql’s healthcare M&A footprint through a private equity acquisition strategy targeting service delivery and client engagement. The announced add on acquisition is described as a tuck-in, marking another Pinnaql acquisitions effort backed by Boomerang, with deal size undisclosed and terms not publicly detailed.
UCB→Candid Therapeutics
May 4, 2026
UCB→Candid Therapeutics
May 3, 2026
Pennant→Senior Living Communities
May 1, 2026
PharmaCorp Rx
May 1, 2026
Legacy Therapeutics→Cansortium Texas
May 1, 2026